一例广泛转移性肝神经内分泌癌患者68Ga-Pentixafor PET/CT与18F-FDG PET/CT表现相似
Similar Findings on 68 Ga-Pentixafor PET/CT and 18 F-FDG PET/CT in a Patient With Widespread Metastatic Hepatic Neuroendocrine Carcinoma.
PubMed 文献 · Clin Nucl Med · 2022-10-17
一名疑似恶性肿瘤患者先行18F-FDG PET/CT,基于表现怀疑多发性骨髓瘤,随后行68Ga-pentixafor PET/CT,结果与18F-FDG PET/CT相似,最终诊断为神经内分泌癌。
要点
- 68Ga-pentixafor PET/CT与18F-FDG PET/CT在本例中表现相似。
- 18F-FDG PET/CT表现曾使患者被怀疑为多发性骨髓瘤。
- 最终诊断为神经内分泌癌。
核心结论
- 广泛转移性肝神经内分泌癌患者中68Ga-pentixafor PET/CT与18F-FDG PET/CT表现相似。
研究设计与样本
- 病例报告:一名疑似恶性肿瘤患者先后行18F-FDG PET/CT与68Ga-pentixafor PET/CT。
主要发现
- 18F-FDG PET/CT表现使患者被怀疑为多发性骨髓瘤。
- 68Ga-pentixafor PET/CT结果与18F-FDG PET/CT相似。
- 患者最终诊断为神经内分泌癌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A patient with suspected malignant tumor underwent 18 F-FDG PET/CT. Based on the findings, the patient was suspected of having multiple myeloma. Then the patient underwent 68 Ga-pentixafor PET/CT, which showed similar results to 18 F-FDG PET/CT. Finally, the patient was eventually diagnosed with neuroendocrine carcinoma.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Deng M, Shu Q, Hu M, et al. Similar Findings on 68 Ga-Pentixafor PET/CT and 18 F-FDG PET/CT in a Patient With Widespread Metastatic Hepatic Neuroendocrine Carcinoma. Clin Nucl Med. 2022. PMID: 36252734. doi:10.1097/RLU.0000000000004442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。